代谢综合征和慢性乙肝：证据足够了吗？
Metabolic syndrome and chronic hepatitis b: is the evidence enough?
预防慢性乙肝是防治肝硬化的根本措施。
The fundamental way of liver cirrhosis prevention and control is to prevent chronic hepatitis B.
代谢综合征在慢性乙肝之上：好还是坏？
Metabolic syndrome on top of chronic hepatitis b: the more, the worse?
结论中医药治疗慢性乙肝疗效好，值得推广。
Conclusion: The traditional medicine has positive effect on CHB, it is worth spreading.
本发明还涉及治疗慢性乙肝药物的制备方法。
The invention also relates to a preparation method of the medicine for treating chronic hepatitis B.
探讨慢性乙肝中医证型与病毒复制之间的关系。
To investigate the relationship between TCM type of syndromes and replication of virus in patients with chronic Hepatitis B.
尤其是对各种慢性乙肝、肝硬化等有独特的诊疗方案。
Especially having unique diagnosing to second chronic various liver, cirrhosis of liver etc. scheme.
慢性乙肝的癌症风险：全基因组协会研究达到目的了吗？
Cancer risk in chronic hepatitis B: Do genome-wide association studies hit the mark?
因此，对于慢性乙肝病人，更应增强对丙肝的检查、诊治。
Therefore, patients with chronic hepatitis B, hepatitis C should enhance the inspection, diagnosis and treatment.
结论：拉米夫定治疗慢性乙肝及乙肝病毒携带者安全有效。
Conclusion: Lamivudin is efficient and safe medicine in the treatment of CHB and HBV carrier.
这代表了对慢性乙肝过继T细胞疗法有吸引力的一类细胞群。
This represents an attractive cell population for adoptive T cell therapy of chronic hepatitis B.
抗病毒治疗应扩大到慢性乙肝和轻度丙氨酸转氨酶升高的患者吗？
Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?
对拉米夫定耐药的慢性乙肝患者面临着病情恶化甚至死亡的危险。
Patients with chronic hepatitis B developing lamivudine resistance are at high risk of disease progression and death.
在慢性乙肝抗病毒治疗中干扰素作为一线治疗取得了一定的疗效。
Interferon has been proved to be the effective first-line therapeutic agent for chronic hepatitis b.
在中国和远东，超过80%的肝细胞癌患者有慢性乙肝病毒的感染。
In parts of China and the Far East, over 80% of HCC patients have chronic HBV infection.
中医辨证治疗能有效地调节慢性乙肝湿热蕴脾证患者的CD细胞功能。
Treatment according to TCM differentiation can availably regulate the function of CD cells in CHB with DH.
唐毕华游选旺【摘要】目的：描述慢性乙肝患者疾病相关知识知晓情况。
Objective: The purposes of this study were to describe the awareness of knowledge about chronic hepatitis B (CHB) in CHB patients.
探讨CD细胞、NK细胞功能在慢性乙肝湿热蕴脾证病理变化中的作用。
To explore the functions of the CD cells and NK cells on the pathologic variety of chronic hepatitis B (CHB) with damp-heat retention spleen syndrome (DH).
急性乙肝患者特异性细胞免疫功能明显强于慢性乙肝患者及肝炎肝硬化患者。
The specific cellular immunity was stronger in the patients with acute hepatitis B than in those with chronic hepatitis B and liver cirrhosis.
方法采用失能调整寿命年指标测量慢性乙肝、肝硬化和肝癌病人的疾病负担。
Methods Disability adjusted life year (DALY) was used to measure BOD of patients with chronic hepatitis B, cirrhosis and liver cancer caused by hepatitis B virus.
急性乙肝病人组与慢性乙肝病人组阳性率差别有统计学意义（P＜0.05）；
The positive rate was significantly different between the acute and chronic hepatitis B patients groups (P<0.05) .
结果中西医对慢性乙肝的认识和治疗，进行了积极的探讨，且中医药有独特的优势。
Results: traditional medicine and western medicine have explored positively about CHB, and the traditional medicine has made unique progress.
目的了解慢性乙型病毒性肝炎(慢性乙肝)患者的健康信念及其与治疗依从性的关系。
Objective To evaluate the health beliefs in patients with chronic hepatitis-B and their relationship with patients' treatment compliance.
结果：85例慢性乙肝患者血清中自身抗体阳性率约为32.94%，明显高于健康对照组。
Results:The positive rate of autoantibodies in chronic hepatitis B was higher in comparison with those in normal group(32.94%, 28/85).
目的研究HBV-DNA多点基因变异在慢性乙肝中的临床意义，为临床诊断和治疗提供依据。
Objective To study clinical meaning of DNA chip technique in detecting the mutation of HBV-DNA ORF, and to offer testimony for clinical diagnosis and treatment.
1998年首个核苷类似物药物拉米夫定推出之前，慢性乙肝病毒感染者可选的有效治疗途径一直都非常有限。
Effective treatment options for individuals with chronic hepatitis B infection were limited until 1998 when lamivudine, the first nucleoside analogue drug, was introduced.
它们彼此相互作用，构成复杂的趋化因子网络系统，在局部慢性乙肝和全身炎症反应中起重要作用。
The chemokine networks have multiply interacted with each other and play a key role in local and systemic inflammatory response.
应用新型基因芯片研究乙肝病毒多点基因变异在慢性乙肝患者中的意义，为临床诊断和治疗提供依据。
ObjectiveTo study clinical meaning of new DNA chip technique in detecting the mutation of HBV-DNA , and to offer testimony for clinical diagnosis and treatment.
结论：慢性乙肝患者对于疾病相关知识的掌握尚欠缺，很多患者具有不良的生活习惯，遵医行为较差。
Conclusions: CHB patients are lack of basic knowledge about this disease, many of them have unhealthy life habits and don't obey the doctors' advice very well.
推测慢性乙肝病患在接触治疗时，由于输入未经抗丙肝病毒抗体检测的血液或血制品，就容易感染上丙肝。
That patients with chronic hepatitis B treatment in contact with, as input, without anti-hepatitis C virus antibody testing of blood or blood products infected with hepatitis C, it is easy.
应用推荐